Related Experiment Video
Updated: Jun 4, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Trends in Opioid Use Disorder in the Veterans Health Administration, 2005-2022
Lauren R Gorfinkel1,2, Carol A Malte3,4, David S Fink2
1Department of Psychiatry, Columbia University Irving Medical Center, New York, New York.
Opioid use disorder (OUD) prevalence in Veterans Health Administration patients nearly doubled from 2005 to 2017, then declined. This trend was mainly driven by non-Hispanic White individuals and those under 65. Public health efforts for OUD prevention and treatment remain crucial.
Area of Science:
- Public Health
- Epidemiology
- Health Services Research
Background:
- Opioid use disorder (OUD) presents significant personal and societal challenges.
- Understanding temporal trends in OUD prevalence is essential for effective service planning.
Purpose of the Study:
- To analyze the time trends in OUD prevalence from 2005 to 2022.
- To examine these trends across different age, sex, and racial/ethnic groups within the Veterans Health Administration (VHA) population.
Main Methods:
- A serial cross-sectional study utilizing national VHA electronic medical record data from 2005 to 2022.
- Inclusion criteria: adult patients (≥18 years) with a current OUD diagnosis receiving outpatient care.
- Analysis involved multivariable logistic regression adjusted for age, sex, and race/ethnicity to assess prevalence changes over time.
Main Results:
- The annual prevalence of OUD diagnoses in VHA patients nearly doubled from 0.60% in 2005 to 1.16% in 2017, then decreased to 0.97% in 2022.
- Similar trends of increase followed by decrease were observed in men, women, and most age groups (under 65) and non-Hispanic White patients.
- Notably, OUD diagnoses increased among patients aged 65+ and decreased among Hispanic/Latino and non-Hispanic Black patients from 2005 to 2022.
Conclusions:
- The prevalence of OUD diagnoses in the VHA population peaked in 2017 and subsequently declined.
- These trends were largely influenced by changes observed in non-Hispanic White patients and those younger than 65 years.
- Ongoing public health initiatives focusing on OUD recognition, treatment, and prevention are necessary.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
12:20Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
Published on: June 10, 2013
Related Concept Videos
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Opioid Receptors: Overview
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...